Answers are grounded in this paper and cite their sources.
A reference case (RC), hereafter referred to as population, intervention, comparator, costs, outcomes, time, ethics & equity, adaptability, modeling (PICCOTEAM) RC, was developed to guide the conduct and reporting for economic evaluations (EEs) of precision medicine (PM). To strengthen its applicability and implementation, a multistakeholder consultative workshop was convened to i) obtain feedback on the feasibility and clarity of PICCOTEAM RC components, ii) identify practical challenges in implementing PM evaluations, and iii) promote shared learning and regional collaboration. This paper summarizes workshop insights and recommends refinements to the PICCOTEAM RC with particular attention to methodological, ethical, and equity considerations in PM policy and reimbursement. The three-day consultative workshop involved 25 participants, comprising five research teams from Singapore ( n = 11), two from Thailand ( n = 5), and nine independent experts. The workshop included presentations on existing challenges in PM EE, an introduction to PICCOTEAM RC, and a World Café session for feedback and refinement. Workshop insights indicated stakeholders considered generic RCs insufficient for guiding PM EEs. Key challenges included uncertainty in modelling outcomes and costs, patient heterogeneity, undefined risk thresholds, complex test-treatment pathways, lack of clinical guidelines, regulatory policies, and intergenerational effects. Key recommendations included clearer population definitions, periodic updates to definitions as PM tests evolve, incorporation of scenario analyses, adoption of societal perspectives where appropriate, and use of expert elicitation when evidence is limited. To enhance uptake and utilisation of the PICCOTEAM RC, stakeholders suggested using it as a mandatory checklist for publications and improving its digital accessibility. The workshop demonstrated the value of deliberative stakeholder engagement in refining RCs for PM. The feedback has informed updates to the PICCOTEAM RC to support more robust, equitable, and context-specific PM evaluations.
No takes yet. Share an insight, caveat, or question.
Butani et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: